UCSF Medical Center selects Bainbridge Health to Support Its Continued Commitment to Medication Safety
News
Relmada Therapeutics Announces Notice of Acceptance of Key Patent in Europe Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms
VenatoRx Pharmaceuticals Receives Award for up to $16 Million from DTRA to Develop a Novel, First-in-Class Antibiotic as Countermeasure against Potential Drug-Resistant Biodefense Category A/B Respiratory Pathogens
Servier and Treventis begin strategic research partnership in neurodegenerative diseases
VenatoRx Pharmaceuticals Receives FDA’s QIDP and Fast Track Designations for Development of its Lead Antibiotic Program